WAYNE, Pa., May 07, 2024 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a global leader in medical technologies, today announced the pre ...

(RTTNews) - Medical technologies firm Teleflex Inc. (TFX) announced Thursday that its UroLift System for treating benign prostatic hyperplasia or BPH has received regulatory clearance in China ...

In a trial pitting medication against the implant, marketed as UroLift (Teleflex, Inc; Pleasanton, CA), men who received the intervention experienced greater improvements in urinary symptoms, as ...

For UroLift, the company saw year-over-year revenue declines in all service sites during the quarter, including hospital, ASC and physician's offices. In the Americas, revenues declined 0.3% year ...

NeoTract, a wholly owned subsidiary of Teleflex Incorporated focused on addressing unmet needs in the field of urology, today announced the presentation of new clinical data at the World Congress ...

The UroLift™ System, a leading minimally invasive treatment for BPH in the U.S., demonstrated faster and more effective results compared to Rezūm in the CLEAR RCT.

NeoTract, a wholly owned subsidiary of Teleflex Incorporated focused on addressing unmet needs in the field of urology, today announced that the American Urological Association (AUA) has ...